Abstract:Data on the distribution of HBV-DNA and other serological markers of hepatitis B virus infection in a population of asymptomatic carriers in Ethiopia are reported. As compared to data from other countries of similar or lower levels of endemicity, it has been found that HBV-DNA prevalence and its correlation with HBeAg/anti-HBe status is similar to that of northern Europe. HBV-DNA is present in 84% of HBe Ag-positive sera but in only 4% of anti-HBe-positive sera, where the lowest concentration of DNA (less than… Show more
“…Then later the magnitude of the peak HBsAg prevalence (10.8%) was available in 1986 and 1989 [25, 26] and then decreased to 6.2% in 2003 [27] and 5.3% in 2007 [28] from the community based studies (Fig. 2a).…”
Section: Resultsmentioning
confidence: 99%
“…2a-d) showed 6.3% (IQR = 5.2–10.8) over the last five decades.
…”
Section: Resultsmentioning
confidence: 99%
“…population, children & ANC attendants39636 (9.1)221 (67.2) a
-19(55.9) d
15(44.0) g
[85]1984NationwideGeneral population50031 (6.2)152 (30.4)16 (3.2)10(32.3) e
8(25.8) e
[52]1987A. AbabaHealth workers43239 (9.02)200 (46.3)316 (73.1)--[29]1989NationwideGeneral population5265569 (10.8)61.4 b
132 (2.5)298(57.1) f
99(19.0) f
[26]1994A.AbabaGeneral population4736292 (6.2)1796(40.7) c
1734 (36.6)-71/279 (25.4)[27]1995A.AbabaChronic liver disease patients23865 (27.0)131 (55.0)---[49]1998Immigrants to IsraelFamilial members50684 (16.6%)---17/84(20.2)[95]2007A. AbabaHIV patients & VCT clients62029 (4.7)-277 (44.7)-3/29(10.3)[42]2010Gamo HPInpatients department clients55626 (4.7)-7 (1.4)--[33]2011A.AbabaHIV patients50015(3.0)58(11.6)--3(0.6)[53]
BackgroundThe existing seroepidemiological data on viral hepatitis in Ethiopia showed a wide variation in prevalence pattern and the clinical and public health burden have been underestimated. The aim of this systematic review and meta-analysis was to provide a clear and comprehensive estimation of viral hepatitis epidemiology and the potential clinical burdens in Ethiopia.MethodsA comprehensive literature search was carried out from five decades (1968–2015) published studies from biomedical databases; PubMed, Google scholar, Medline and Web of Science.ResultsThe overall pooled prevalence of hepatitis B virus (HBV) was 7.4% (95%CI: 6.5–8.4). The pooled prevalence among subgroups showed 5.2% (95%CI: 3.7–7.4) in human immunodeficiency virus (HIV) infected individuals, 8.0% (95%CI: 5.9–10.7) in community based studies, 8.4% (95%CI: 5.4–12.7) in blood donors, 11.0% (95%CI: 7.5–15.9) in immigrants and 6.9% (95%CI: 5.6–8.5) in other groups. Among study parameters considered during meta-regression analysis, only study years were associated with a decreasing HBV prevalence rate over time. The overall pooled prevalence of anti-hepatitis C virus antibody (anti-HCV) was 3.1% (95%CI: 2.2–4.4). Unlike HBV, the anti-HCV prevalence in HIV infected individuals was higher (5.5%, 95%CI: 3.8–7.8%, p = 0.01) than the prevalence observed in the other subgroup of study population. Although relatively few data were available, hepatitis virus A (HAV), D (HDV) and E (HEV) were also circulated in Ethiopia.ConclusionsThis review indicates that all types of viral hepatitis origins are endemic in Ethiopia. Adapting a recommended diagnostic and treatment algorithm of viral hepatitis in the routine healthcare systems and implementing prevention and control policies in the general population needs an urgent attention.Electronic supplementary materialThe online version of this article (doi:10.1186/s12879-016-2090-1) contains supplementary material, which is available to authorized users.
“…Then later the magnitude of the peak HBsAg prevalence (10.8%) was available in 1986 and 1989 [25, 26] and then decreased to 6.2% in 2003 [27] and 5.3% in 2007 [28] from the community based studies (Fig. 2a).…”
Section: Resultsmentioning
confidence: 99%
“…2a-d) showed 6.3% (IQR = 5.2–10.8) over the last five decades.
…”
Section: Resultsmentioning
confidence: 99%
“…population, children & ANC attendants39636 (9.1)221 (67.2) a
-19(55.9) d
15(44.0) g
[85]1984NationwideGeneral population50031 (6.2)152 (30.4)16 (3.2)10(32.3) e
8(25.8) e
[52]1987A. AbabaHealth workers43239 (9.02)200 (46.3)316 (73.1)--[29]1989NationwideGeneral population5265569 (10.8)61.4 b
132 (2.5)298(57.1) f
99(19.0) f
[26]1994A.AbabaGeneral population4736292 (6.2)1796(40.7) c
1734 (36.6)-71/279 (25.4)[27]1995A.AbabaChronic liver disease patients23865 (27.0)131 (55.0)---[49]1998Immigrants to IsraelFamilial members50684 (16.6%)---17/84(20.2)[95]2007A. AbabaHIV patients & VCT clients62029 (4.7)-277 (44.7)-3/29(10.3)[42]2010Gamo HPInpatients department clients55626 (4.7)-7 (1.4)--[33]2011A.AbabaHIV patients50015(3.0)58(11.6)--3(0.6)[53]
BackgroundThe existing seroepidemiological data on viral hepatitis in Ethiopia showed a wide variation in prevalence pattern and the clinical and public health burden have been underestimated. The aim of this systematic review and meta-analysis was to provide a clear and comprehensive estimation of viral hepatitis epidemiology and the potential clinical burdens in Ethiopia.MethodsA comprehensive literature search was carried out from five decades (1968–2015) published studies from biomedical databases; PubMed, Google scholar, Medline and Web of Science.ResultsThe overall pooled prevalence of hepatitis B virus (HBV) was 7.4% (95%CI: 6.5–8.4). The pooled prevalence among subgroups showed 5.2% (95%CI: 3.7–7.4) in human immunodeficiency virus (HIV) infected individuals, 8.0% (95%CI: 5.9–10.7) in community based studies, 8.4% (95%CI: 5.4–12.7) in blood donors, 11.0% (95%CI: 7.5–15.9) in immigrants and 6.9% (95%CI: 5.6–8.5) in other groups. Among study parameters considered during meta-regression analysis, only study years were associated with a decreasing HBV prevalence rate over time. The overall pooled prevalence of anti-hepatitis C virus antibody (anti-HCV) was 3.1% (95%CI: 2.2–4.4). Unlike HBV, the anti-HCV prevalence in HIV infected individuals was higher (5.5%, 95%CI: 3.8–7.8%, p = 0.01) than the prevalence observed in the other subgroup of study population. Although relatively few data were available, hepatitis virus A (HAV), D (HDV) and E (HEV) were also circulated in Ethiopia.ConclusionsThis review indicates that all types of viral hepatitis origins are endemic in Ethiopia. Adapting a recommended diagnostic and treatment algorithm of viral hepatitis in the routine healthcare systems and implementing prevention and control policies in the general population needs an urgent attention.Electronic supplementary materialThe online version of this article (doi:10.1186/s12879-016-2090-1) contains supplementary material, which is available to authorized users.
“…12 Community-based seroepidemiological surveys are few in Ethiopia and the available studies indicate the varied distribution of HBV infection across geographical regions of the country. [13][14][15] In addition, previous community-based studies were old and did not show the current burden of the virus. 13,14 Knowledge on the prevalence of HBV infection in the general population is significant for health-care workers and policymakers since the risk of health-care workers to occupational exposure with infected body fluids depends upon the prevalence of HBV in the general population.…”
Purpose: Ethiopia is grouped with countries with no national strategy for surveillance of viral hepatitis. Hence, data on hepatitis B virus (HBV) infection in the general population are limited. The aim of this study was to estimate the prevalence and associated factors of HBV infection among adults in Southwest Ethiopia. Materials and Methods: A community-based cross-sectional study was conducted in
“…There is a body of literature on hepatitis B in Ethiopia relating its public health importance [17][18][19], and giving information on the pattern of HBV markers in various geographical locations, age and social groups, and risk categories [9,[20][21][22][23][24][25][26][27][28]. Our study builds upon this earlier work, providing significantly more detailed and representative data on HBV marker seroprevalence for the capital city of Addis Ababa.…”
SUMMARYA community-based seroepidemiological survey of Addis Ababa, Ethiopia was conducted in 1994 to inform on the transmission dynamics and control of hepatitis B virus (HBV) infection. Venous blood from 4736 individuals under 50 years of age from 1262 households, selected using stratified cluster-sampling, was screened for HBV markers using commercial ELISAs. HBsAg prevalence was 7% (95 % CI 6-8), higher in males (9 % ; 7-10) than females (5 %; 4-6). HBeAg prevalence in HBsAg positives was 23 % (18-29), and less than 1 % of women of childbearing age were HBeAg positive. Overall HBV seroprevalence (any marker), rose steadily with age to over 70 % in 40-49 year olds, indicating significant childhood and adult transmission. Estimated instantaneous incidence was 3-4/100 susceptibles/year, higher in males than females in 0-4 year olds, and peaking in early childhood and young adults. The age at which 50 % had evidence of infection was around 20 years, and the herd immunity threshold is approximated at 63-77%. Addis Ababa is of intermediate-high HBV endemicity, with negligible perinatal transmission. Our main findings are the identification of a significant difference between males and females in the age-acquisition of HBV infection, and marked differences between age groups in HBV incidence rates. These results should target future research studies of underlying risk factors. Furthermore, we generate a crude estimate of the level of coverage of HBV vaccine that would be required to eliminate the virus from the study population.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.